FIELD: medicine.
SUBSTANCE: cultured embryo cell viability is evaluated by the content of regulatory peptide HGF in a culture medium.
EFFECT: invention can be used in cell viability evaluation for transplantology.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR PRODUCING A LYOPHILISATE OF LIVER CELL CULTURE ENRICHED WITH HEPATOCYTE GROWTH FACTOR | 2021 |
|
RU2781448C1 |
MEDIUM FOR CULTIVATING BONE MARROW CELLS INTENDED FOR CELLULAR THERAPY | 2020 |
|
RU2756926C1 |
LIVER ORGANOID, VERSIONS OF USE THEREOF AND CULTURE METHOD FOR PRODUCTION THEREOF | 2011 |
|
RU2579995C2 |
METHOD FOR LONG-TERM CULTIVATION AND EXPANSION OF NK CELLS WITH HIGH VIABILITY AND FUNCTIONAL ACTIVITY | 2021 |
|
RU2794770C1 |
MEDIUM FOR CONSERVATION OF LANGERHANS ISLETS | 2005 |
|
RU2290433C2 |
METHOD FOR PRODUCING NEURONAL MATRIX | 2010 |
|
RU2431666C1 |
CELL PRODUCT OF INSULIN-PRODUCING MAMMALIAN CELLS AND USE THEREOF FOR DIABETES MELLITUS THERAPY | 2017 |
|
RU2663118C1 |
METHOD FOR PREPARING CELLS FOR REPLACEMENT CELL THERAPY OF HEPATIC PATHOLOGY | 2012 |
|
RU2510276C1 |
CULTURE MEDIUM FOR STEM CELLS | 2012 |
|
RU2714256C2 |
METHOD OF PREPARING SKIN CELL MATRIX | 2008 |
|
RU2391399C2 |
Authors
Dates
2009-09-10—Published
2007-12-03—Filed